Filip Lhota

428 total citations
11 papers, 185 citations indexed

About

Filip Lhota is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Filip Lhota has authored 11 papers receiving a total of 185 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Filip Lhota's work include BRCA gene mutations in cancer (5 papers), DNA Repair Mechanisms (4 papers) and Genetic factors in colorectal cancer (3 papers). Filip Lhota is often cited by papers focused on BRCA gene mutations in cancer (5 papers), DNA Repair Mechanisms (4 papers) and Genetic factors in colorectal cancer (3 papers). Filip Lhota collaborates with scholars based in Czechia, Slovakia and Mexico. Filip Lhota's co-authors include Zdeněk Kleibl, Petra Kleiblová, Markéta Janatová, J. Hojný, Katri Koli, Jorma Keski‐Oja, Pavel Souček, Petra Zemánková, Jana Soukupová and Ondřej Havránek and has published in prestigious journals such as PLoS ONE, Gene and Journal of Cellular Physiology.

In The Last Decade

Filip Lhota

9 papers receiving 180 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Filip Lhota Czechia 9 111 74 44 43 36 11 185
Maria K. Haanpää Finland 8 124 1.1× 115 1.6× 34 0.8× 31 0.7× 31 0.9× 25 199
Sheehyun Kim South Korea 8 51 0.5× 43 0.6× 74 1.7× 61 1.4× 39 1.1× 24 166
Mitchell W. Dillon United States 5 127 1.1× 81 1.1× 18 0.4× 26 0.6× 15 0.4× 7 202
Makia J. Marafie Kuwait 11 142 1.3× 154 2.1× 79 1.8× 37 0.9× 50 1.4× 28 279
Bryce A. Seifert United States 7 90 0.8× 140 1.9× 82 1.9× 40 0.9× 67 1.9× 15 229
Francesc Muyas United Kingdom 8 115 1.0× 50 0.7× 97 2.2× 40 0.9× 19 0.5× 16 204
Tauanne Dias Amarante Brazil 5 150 1.4× 37 0.5× 107 2.4× 37 0.9× 31 0.9× 8 217
Giulia Daniele Italy 5 146 1.3× 43 0.6× 109 2.5× 33 0.8× 29 0.8× 8 212
Tereza Vaclová United States 8 132 1.2× 74 1.0× 40 0.9× 61 1.4× 21 0.6× 12 205
Alice Fiévet France 9 104 0.9× 45 0.6× 39 0.9× 57 1.3× 20 0.6× 15 187

Countries citing papers authored by Filip Lhota

Since Specialization
Citations

This map shows the geographic impact of Filip Lhota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filip Lhota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filip Lhota more than expected).

Fields of papers citing papers by Filip Lhota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filip Lhota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filip Lhota. The network helps show where Filip Lhota may publish in the future.

Co-authorship network of co-authors of Filip Lhota

This figure shows the co-authorship network connecting the top 25 collaborators of Filip Lhota. A scholar is included among the top collaborators of Filip Lhota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filip Lhota. Filip Lhota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Janatová, Markéta, Eva Macháčková, Jana Soukupová, et al.. (2023). Classification of germline variants identified in cancer predisposition genetic testing – consensus of the CZECANCA consortium. Klinicka onkologie. 36(6). 431–439.
2.
Brožková, Dana Šafka, Petra Laššuthová, Lukáš Varga, et al.. (2021). The Cause of Hereditary Hearing Loss in GJB2 Heterozygotes—A Comprehensive Study of the GJB2/DFNB1 Region. Genes. 12(5). 684–684. 10 indexed citations
3.
Soukupová, Jana, Petra Zemánková, Michal Vočka, et al.. (2019). Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic. Klinicka onkologie. 32(Suppl 2). 72–78. 1 indexed citations
4.
Soukupová, Jana, Petra Zemánková, Markéta Janatová, et al.. (2018). Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes. PLoS ONE. 13(4). e0195761–e0195761. 18 indexed citations
5.
Hojný, J., Petra Zemánková, Filip Lhota, et al.. (2017). Multiplex PCR and NGS-based identification of mRNA splicing variants: Analysis of BRCA1 splicing pattern as a model. Gene. 637. 41–49. 9 indexed citations
6.
Borecká, Marianna, Petra Zemánková, Filip Lhota, et al.. (2016). The c.657del5 variant in the NBN gene predisposes to pancreatic cancer. Gene. 587(2). 169–172. 12 indexed citations
7.
Lhota, Filip, Petra Zemánková, Petra Kleiblová, et al.. (2016). Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2‐negatively tested breast cancer patients. Clinical Genetics. 90(4). 324–333. 25 indexed citations
8.
Havránek, Ondřej, Petra Kleiblová, J. Hojný, et al.. (2015). Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma. PLoS ONE. 10(10). e0140819–e0140819. 36 indexed citations
9.
10.
Ševčı́k, Jan, Martin Falk, Petra Kleiblová, et al.. (2012). The BRCA1 alternative splicing variant Δ14-15 with an in-frame deletion of part of the regulatory serine-containing domain (SCD) impairs the DNA repair capacity in MCF-7 cells. Cellular Signalling. 24(5). 1023–1030. 17 indexed citations
11.
Lhota, Filip, et al.. (2010). Independent regulation of short and long forms of latent TGF‐β binding protein (LTBP)‐4 in cultured fibroblasts and human tissues. Journal of Cellular Physiology. 223(3). 727–736. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria K. Haanpää Breakdown of academic impact, for papers by Sheehyun Kim Breakdown of academic impact, for papers by Mitchell W. Dillon Breakdown of academic impact, for papers by Makia J. Marafie Breakdown of academic impact, for papers by Bryce A. Seifert Breakdown of academic impact, for papers by Francesc Muyas Breakdown of academic impact, for papers by Tauanne Dias Amarante Breakdown of academic impact, for papers by Giulia Daniele Breakdown of academic impact, for papers by Tereza Vaclová Breakdown of academic impact, for papers by Alice Fiévet
Rankless by CCL
2026